Literature DB >> 26093953

Lipiodol lOcalization for Ground-glass opacity mInimal Surgery: Rationale and design of the LOGIS trial.

Chul Hwan Park1, Jin Hur2, Sang Min Lee3, Ji Won Lee4, Sung Ho Hwang5, Jae Seung Seo6, Kye Ho Lee7, Woo Cheol Kwon8, Tae Hoon Kim1, Byoung Wook Choi9.   

Abstract

OBJECTIVES: The diagnosis and treatment of ground-glass opacity (GGO) lesions have become important issues because subsolid nodules including GGO are known to frequently represent the histologic spectrum of lung adenocarcinoma. Because small GGO lesions cannot usually be palpated or visualized during surgery, several marking techniques have been reported for localization during thoracoscopic surgery, such as lipiodol and hook-wire localization. This study is designed to demonstrate the usefulness and safety of the lipiodol localization technique for individuals undergoing GGO VATS resection compared to the hook-wire localization technique.
METHODS: Two hundred fifty participants will be prospectively enrolled in a 1:1 manner to the lipiodol or hook-wire group according to the inclusion criteria. All study participants will undergo preoperative lung localization using either the lipiodol or hook-wire method. Thoracoscopic surgery will be performed by experienced thoracoscopic surgeons within several hours after marking under general anesthesia. The primary endpoint is the procedure success rate, and the secondary endpoints are the procedure complication rate, procedure time, surgery time and the margin from the lesion in the resected specimen.
RESULTS: Patient enrollment will be completed within 2years. We will analyze the procedure success rate and the presence of complications with regard to the CT results. In addition, the procedure and surgery times, and the safety margin will be also compared between the 2 techniques.
CONCLUSION: If the aims of this study are achieved, then the use of lipiodol localization technique will be widespread in the localization of non-palpable pulmonary lesions that are indicated for surgical resection. (ClinicalTrials.gov: NCT02180568).
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ground-glass opacity (GGO); Hook-wire; Lipiodol; Localization; Video-assisted thoracic surgery (VATS)

Mesh:

Substances:

Year:  2015        PMID: 26093953     DOI: 10.1016/j.cct.2015.06.009

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  5 in total

1.  Preoperative localisation of pulmonary ground-glass opacity using medical adhesive before thoracoscopic resection.

Authors:  Ren-Li Cen; Fei Cui; Qi Wan; Ling Chen; Xiao-Yan Huang; Jia-Xuan Zhou; Shu-Ben Li; Qing-Si Zeng; Jian-Xing He
Journal:  Eur Radiol       Date:  2018-04-17       Impact factor: 5.315

2.  Three-dimensional printed navigational template for localizing small pulmonary nodules: A case-controlled study.

Authors:  Rui Fu; Yun-Fei Chai; Jia-Tao Zhang; Tao Zhang; Xiao-Kun Chen; Song Dong; Hong-Hong Yan; Xue-Ning Yang; Mei-Ping Huang; Yi-Long Wu; Jian Zhuang; Wen-Zhao Zhong
Journal:  Thorac Cancer       Date:  2020-07-19       Impact factor: 3.500

3.  Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma.

Authors:  Dong Jin Im; Sang Min Lee; Kyunghwa Han; Chul Hwan Park; Ji Won Lee; Sung Ho Hwang; Jae Seung Seo; Woocheol Kwon; Kye Ho Lee; Jin Hur
Journal:  Thorac Cancer       Date:  2021-02-07       Impact factor: 3.500

4.  Recent advances in electromagnetic navigation bronchoscopy for localization of peripheral pulmonary nodules.

Authors:  Yuichi Saito
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

5.  LOGIS (LOcalization of Ground-glass-opacity and pulmonary lesions for mInimal Surgery) registry: Design and Rationale.

Authors:  Chul Hwan Park; Dong Jin Im; Sang Min Lee; Ji Won Lee; Sung Ho Hwang; Semin Chong; Min Jae Cha; Kye Ho Lee; Woocheol Kwon; Hwan Seok Yong; Jae Wook Lee; Gong Yong Jin; Sang Hyun Paik; Kyunghwa Han; Jin Hur
Journal:  Contemp Clin Trials Commun       Date:  2017-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.